UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

JNCI : Journal of the National Cancer Institute, 2019-03, Vol.111 (3), p.245-255

2019

Volltextzugriff (PDF)

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

JNCI : Journal of the National Cancer Institute, 2021-03, Vol.113 (3), p.244-257

2021

Volltextzugriff (PDF)

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486

2022

Volltextzugriff (PDF)

New strategies in ovarian cancer treatment

Cancer, 2019-12, Vol.125 (S24), p.4623-4629

2019

Volltextzugriff (PDF)

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3014-3022

2016

Volltextzugriff (PDF)

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

Supportive care in cancer, 2013-06, Vol.21 (6), p.1525-1550

2013

Volltextzugriff (PDF)

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-07, Vol.320 (2), p.167

2018

Volltextzugriff (PDF)

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

JNCI : Journal of the National Cancer Institute, 2013-08, Vol.105 (15), p.1132-1141

2013

Volltextzugriff (PDF)

Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer

Journal of clinical oncology, 2012-06, Vol.30 (16), p.1980-1988

2012

Volltextzugriff (PDF)

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.dju129-dju129

2014

Volltextzugriff (PDF)

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

The New England journal of medicine, 2013-08, Vol.369 (7), p.603-610

2013

Volltextzugriff (PDF)

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study

Journal of clinical oncology, 2018-11, Vol.36 (32), p.JCO2018786624-3239

2018

Volltextzugriff (PDF)

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.409-418

2017

Volltextzugriff (PDF)

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

JAMA : the journal of the American Medical Association, 2011-10, Vol.306 (14), p.1549

2011

Volltextzugriff (PDF)

Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy

Journal of clinical oncology, 2013-07, Vol.31 (20), p.2627-2633

2013

Volltextzugriff (PDF)

Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives

Cancer epidemiology, biomarkers & prevention, 2022-03, Vol.31 (3), p.512-514

2022

Volltextzugriff (PDF)

Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk

JNCI : Journal of the National Cancer Institute, 2014-03, Vol.106 (3), p.djt456

2014

Volltextzugriff (PDF)

Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study

The lancet oncology, 2018-02, Vol.19 (2), p.207-215

2018

Volltextzugriff (PDF)

Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design

Cancer, 2020-10, Vol.126 (20), p.4602-4613

2020

Volltextzugriff (PDF)

Study design considerations for trials to evaluate multicancer early detection assays for clinical utility

JNCI : Journal of the National Cancer Institute, 2023-03, Vol.115 (3), p.250-257

2023

Volltextzugriff (PDF)

Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?

Cancer, 2017-05, Vol.123 (10), p.1699-1702

2017

Volltextzugriff (PDF)

Increasing power in screening trials by testing control-arm specimens: Application to multicancer detection screening

JNCI : Journal of the National Cancer Institute, 2024-04, Vol.116 (8), p.1280-1287

2024

Volltextzugriff (PDF)

What Keeps Patients Out of Clinical Trials?

JCO oncology practice, 2020-03, Vol.16 (3), p.125-127

2020

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(230)

Publikationsform

Artikel
(255)
Buchkapitel
(4)

Sprache

Englisch
(259)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(170)
Life Sciences & Biomedicine
(169)
Humans
(145)
Oncology
(129)
Middle Aged
(76)
Female
(73)
Aged
(65)
Male
(59)
Adult
(51)
Cancer
(43)
Clinical Trials
(42)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Tumors
(39)
United States
(39)
Treatment Outcome
(28)
National Cancer Institute
(23)
Neoplasms - Drug Therapy
(22)
Prostatic Neoplasms - Prevention & Control
(21)
Aged, 80 And Over
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

New strategies in ovarian cancer treatment

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

Prevention and early detection of prostate cancer

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy

Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives

Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk

Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study

Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design

Study design considerations for trials to evaluate multicancer early detection assays for clinical utility

Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?

Increasing power in screening trials by testing control-arm specimens: Application to multicancer detection screening

What Keeps Patients Out of Clinical Trials?

Suchergebnisse filtern